临床医学工程
臨床醫學工程
림상의학공정
Clinical Medical & Engineering
2015年
10期
1341-1342
,共2页
布地奈德%雾化吸入%小儿肺炎%支原体感染
佈地奈德%霧化吸入%小兒肺炎%支原體感染
포지내덕%무화흡입%소인폐염%지원체감염
Budesonide%Aerosol inhalation%infantile pneumonia%Mycoplasma infection
目的：探讨小儿肺炎支原体感染辅助布地奈德雾化吸入治疗的疗效。方法选取我院2012年7月至2014年11月收治的280例肺炎支原体感染患儿为研究对象，随机分为两组各140例。对照组行常规综合治疗，观察组在此基础上辅以布地奈德雾化吸入疗法进行治疗。记录比较两组疗效及不良反应情况；比较两组体征消失时间、住院时间及再感染次数。结果观察组总有效率为94.29%，显著高于对照组的80.00%，差异有统计学意义(P ＜0.01)。观察组不良反应发生率为5.00%，与对照组的3.57%对比，差异无统计学意义(P＞0.05)。观察组湿啰音消退、气喘缓解、退烧、止咳及住院时间均显著短于对照组，再感染次数显著低于对照组，差异均具有统计学意义(P＜0.01)。结论布地奈德混悬液雾化吸入治疗小儿支原体肺炎疗效显著，安全可靠，值得推广。
目的：探討小兒肺炎支原體感染輔助佈地奈德霧化吸入治療的療效。方法選取我院2012年7月至2014年11月收治的280例肺炎支原體感染患兒為研究對象，隨機分為兩組各140例。對照組行常規綜閤治療，觀察組在此基礎上輔以佈地奈德霧化吸入療法進行治療。記錄比較兩組療效及不良反應情況；比較兩組體徵消失時間、住院時間及再感染次數。結果觀察組總有效率為94.29%，顯著高于對照組的80.00%，差異有統計學意義(P ＜0.01)。觀察組不良反應髮生率為5.00%，與對照組的3.57%對比，差異無統計學意義(P＞0.05)。觀察組濕啰音消退、氣喘緩解、退燒、止咳及住院時間均顯著短于對照組，再感染次數顯著低于對照組，差異均具有統計學意義(P＜0.01)。結論佈地奈德混懸液霧化吸入治療小兒支原體肺炎療效顯著，安全可靠，值得推廣。
목적：탐토소인폐염지원체감염보조포지내덕무화흡입치료적료효。방법선취아원2012년7월지2014년11월수치적280례폐염지원체감염환인위연구대상，수궤분위량조각140례。대조조행상규종합치료，관찰조재차기출상보이포지내덕무화흡입요법진행치료。기록비교량조료효급불량반응정황；비교량조체정소실시간、주원시간급재감염차수。결과관찰조총유효솔위94.29%，현저고우대조조적80.00%，차이유통계학의의(P ＜0.01)。관찰조불량반응발생솔위5.00%，여대조조적3.57%대비，차이무통계학의의(P＞0.05)。관찰조습라음소퇴、기천완해、퇴소、지해급주원시간균현저단우대조조，재감염차수현저저우대조조，차이균구유통계학의의(P＜0.01)。결론포지내덕혼현액무화흡입치료소인지원체폐염료효현저，안전가고，치득추엄。
Objective To investigate the effect of budesonide inhalation in adjuvant treatment of mycoplasma pneumoniae infection in children. Methods 280 cases of children with mycoplasma pneumoniae infection treated in our hospital from July 2012 to November 2014 were selected and randomly divided into two groups, with 140 cases in each group. The control group was given routine comprehensive treatment, the observation group was given budesonide inhalation therapy on the basis of control group. The clinical effect and incidence of adverse reactions in two groups were compared, and the disappearance time of physical signs, hospitalization time and reinfection times were also compared. Results The total effective rate of observation group was 94.29%, significantly higher than 80.00%of control group, with statistical difference (P <0.01). The incidence of adverse reactions of observation group was 5.00%, and had no statistical difference compared with 3.57% of control group (P >0.05). The extinction time of moist rale, alleviation time of asthma, fever and cough, hospitalization time of observation group were significantly shorter than those of control group, the reinfection times of observation group was significantly lower than that of control group, all the difference was statistical (P <0.01). Conclusions Budesonide inhalation has significant effect in the treatment of children with mycoplasma pneumonia, which is safe and reliable and worthy of promotion.
